Rhythm Pharmaceuticals, Inc.
RYTM · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $190M | $130M | +45.8% |
| Operating income | −$192M | −$266M | +27.7% |
| Net income | −$202M | −$265M | +23.7% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 3, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $92.1M | $51.3M | +79.5% |
| Operating income | −$39.3M | −$52.7M | +25.4% |
| Net income | −$41.4M | −$52.9M | +21.7% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Rhythm Pharmaceuticals's revenue in FY2025?
- $190M in FY2025 (Fiscal year ended Dec 31, 2025), +45.8% vs $130M a year earlier, per its 10-K filed Feb 2026.
- Was Rhythm Pharmaceuticals profitable in FY2025?
- No: net income was −$202M and operating income −$192M in FY2025.
- What was Rhythm Pharmaceuticals's revenue in Q3 2026?
- $92.1M (+79.5% vs a year earlier), per its Form 10-Q filed Nov 3, 2026.